FDA Warns Retailers of Unauthorized ELFBAR, LOST MARY E-Cigarette Sales to Teens

Regulations by 2FIRSTS.ai

Jul.26.2024

FDA Warns Retailers of Unauthorized ELFBAR, LOST MARY E-Cigarette Sales to Teens

FDA warns 80 retailers in 15 states for selling unauthorized e-cigarettes popular among youth, imposing fines on non-compliant stores.

On July 25th, the US Food and Drug Administration (FDA) issued warning letters to 80 physical retail stores in 15 states for selling unauthorized e-cigarette products popular among teenagers, including brands like ELFBAR and Lost Mary.

At the same time, the FDA announced that it has taken civil monetary penalty (CMP) actions against eight retailers who had previously received warnings for selling unauthorized e-cigarettes but had not taken any action. Each retailer is required to pay a fine of $20,678.

Warning letters and CMPs are the result of FDA using multiple monitoring systems to identify products that are appealing to or targeting youth. After confirming or investigating violations, the FDA will first send a warning letter, and recipients have 15 working days to respond with a plan of action to correct current violations and prevent future ones.

In the past year, the FDA has conducted inspections on retailers to identify those selling unauthorized e-cigarettes. As a result of these actions, the FDA has issued over 690 warning letters and taken over 140 civil enforcement actions against retailers selling unauthorized e-cigarettes.

So far, the FDA has authorized 34 types of e-cigarette products and devices, which are currently the only e-cigarette products that may be legally sold in the United States.

References:

[1] FDA Issues Warning Letters to 80 Retailers for Selling Unauthorized Elf Bar and Lost Mary E-Cigarettes

Also Read:

[1] FDA Authorizes 7 VUSE Tobacco-Flavored E-cigarette Products for Sale in US

[2] US Congress Orders FDA Crackdown on Illegal Disposables, Prioritizing Flavored Ones

[3] FDA-Authorized VUSE E-Cigarettes: Diverse Nicotine Levels in Tobacco Flavors

[4] FDA to Launch Next Generation CTP Portal Next Year

#North America #United States #Legislation #Open system e-cigarettes #FDA

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

ceshi1111

Trusted by industry leaders and innovators, ARAC brings unmatched expertise in Modules 5 & 6, including label and claim development, comprehension testing, human factors/usability, and clinical-behavioral research such as actual use and switching studies. These studies generate the robust, real-world evidence needed to evaluate whether products are “Appropriate for the Protection of Public Health” (APPH) -- including randomized experimental longitudinal, actual use, cohort st

Oct.21

2Firsts Interview with IBVTA: UK Vape Tax May Weaken Harm Reduction Efforts

As the UK prepares to introduce its first-ever vape tax in 2026, questions are growing about how the measure will reshape the country’s harm reduction landscape. IBVTA tells 2Firsts that while it was not in favour of the new duty, it accepts that it is being implemented and is working with regulators to ensure a smooth rollout — warning, however, that higher costs could slow smokers’ transition to safer alternatives.

Oct.07

Philip Morris USA Reaches $66M Settlement With Washington State Over MSA Payment Dispute

Philip Morris USA has reached a settlement with Washington State and agreed to pay $66 million to resolve disputes over annual payments under the 1998 Master Settlement Agreement (MSA) for the period 2005–2015.

Nov.04 by 2FIRSTS.ai

Following Japan debut, IQOS ILUMA i “Seletti Edition” limited series launches in South Korea.

Philip Morris International (PMI) Korea announced a collaboration with Italian design brand Seletti to launch the IQOS ILUMA i limited “Seletti Edition.” Pre-sales begin on the 29th at IQOS.com for IQOS Club Gold and Platinum members, with sales from the 30th via the website and nine IQOS-owned stores nationwide. PMI previously said the series would debut in Japan first before rolling out to 13 global travel-retail markets.